PROM1 and glioblastoma: Moreover, EphA2 expression increases in GBM stem cells (GSCs), a subpopulation of GBM cells resistant to conventional therapies, and being co-expressed with other stem cell markers, such as CD133 and integrin alpha 7, it represents an important molecular feature of GBM stemness.